On Mar. 24, 2020, T2 Biosystems announced it has entered into a worldwide licensing agreement for a rapid COVID-19, novel coronavirus test developed by the Center of Discovery and Innovation at Hackensack Meridian Health, New Jerseyﾒs largest and most comprehensive health network.

Under terms of the agreement, T2 Biosystems will adapt the coronavirus test to run on its T2Dxﾮ Instrument, the same instrument used for the FDA-cleared T2Bacteriaﾮ and T2Candidaﾮ Panels.